These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 8418053)

  • 1. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
    Wu HY; Russell MW
    Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.
    Russell MW; Wu HY
    Infect Immun; 1991 Nov; 59(11):4061-70. PubMed ID: 1937766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
    Wu HY; Russell MW
    Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
    Toida N; Hajishengallis G; Wu HY; Russell MW
    Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.
    Katz J; Harmon CC; Buckner GP; Richardson GJ; Russell MW; Michalek SM
    Infect Immun; 1993 May; 61(5):1964-71. PubMed ID: 8478086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
    Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M
    Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
    Harokopakis E; Hajishengallis G; Michalek SM
    Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
    Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
    Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein.
    Gockel CM; Russell MW
    Immunology; 2005 Dec; 116(4):477-86. PubMed ID: 16313361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization.
    Wu HY; Nikolova EB; Beagley KW; Eldridge JH; Russell MW
    Infect Immun; 1997 Jan; 65(1):227-35. PubMed ID: 8975916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
    Menge AC; Michalek SM; Russell MW; Mestecky J
    Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence and recall of immune responses in aged mice after mucosal immunization.
    Harrod T; Martin M; Russell MW
    Oral Microbiol Immunol; 2001 Jun; 16(3):170-7. PubMed ID: 11358539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of female genital tract antibody responses by local or central (common) mucosal immunization.
    Wu HY; Abdu S; Stinson D; Russell MW
    Infect Immun; 2000 Oct; 68(10):5539-45. PubMed ID: 10992451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity.
    Wu HY; Russell MW
    Vaccine; 1994; 12(3):215-22. PubMed ID: 8165853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
    Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
    J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.
    Childers NK; Miller KL; Tong G; Llarena JC; Greenway T; Ulrich JT; Michalek SM
    Infect Immun; 2000 Oct; 68(10):5509-16. PubMed ID: 10992447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
    Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.